The Internally Discriminated Priming System (IDPS), a proprietary technology of GENECAST, is an innovative system that detects genetic changes quickly and accurately, unmatched by other technologies. The cause of all cancers is genetic changes. The paradigm shift of diagnosis, prevention and treatment by the IDPS cancer screening system will bring freedom from fear of cancer.
Location: South Korea
Sector: Biotech, Health Care